Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02283658
Title Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic

fallopian tube carcinoma

peritoneal carcinoma

ovarian carcinoma


Everolimus + Letrozole

Age Groups: adult
Covered Countries USA

No variant requirements are available.